Cognia Corporation To Introduce Proprietary Ubiquitin Database At Drug Discovery Conference

Published: Jun 21, 2006

NEW YORK--(BUSINESS WIRE)--June 21, 2006--Cognia Corp., a pioneer in developing and aggregating biological information, today announced it will unveil its first proprietary database, Cognia Catabolism, covering key regulatory proteins of the ubiquitin system at the June 26 "Ubiquitin in Drug Discovery and Development" Conference.

Back to news